Nikodimopoulou M, Karakasi K, Daoudaki M, Fouza A, Vagiotas L, Myserlis G, Antoniadis N, Salveridis N, Fouzas I
Division of Transplantation, Department of Surgery, Hippokration General Hospital, Thessaloniki, Greece.
Division of Transplantation, Department of Surgery, Hippokration General Hospital, Thessaloniki, Greece.
Transplant Proc. 2019 Mar;51(2):405-407. doi: 10.1016/j.transproceed.2019.01.019. Epub 2019 Jan 4.
The program Old for Old or European Senior Program (ESP), allocates donors aged ≥65 years to recipients of ≥65, within a narrow geographic area in order to minimize cold ischemia time, decrease the waiting time for elderly patients listed for kidney transplantation and expand the transplant resource in this group. The ESP is not officially applied in Greece. In our center, the Old for Old criteria have been used since 2003 for elderly patients who are candidates for kidney transplantation.
We aimed to retrospectively evaluate the results of kidney transplantation from donors ≥65 years to recipients ≥65 years (Old for Old group), by examining a 5-year actual survival of the recipient and the graft. Ten Old for Old transplantations were performed at our center and the graft and patient survival was estimated during a 5-year follow-up. This group was compared to a control group of 10 recipients under the age of 65, who received grafts from deceased donors aged ≥65 years; it was found that graft and patient survival was significantly lower in the Old for Old group (50% and 58% respectively), compared to the control group, with graft and patient survival 72% and 80%, respectively (P < .05). The main cause of death was cardiovascular disease.
More studies with higher number of patients are needed for the assessment of survival outcome between the elderly transplanted patient and those on dialysis listed for renal allografts to conclude whether Old for Old transplantation is beneficial. It is also important to consider a better pre-transplant medical evaluation with attention to cardiovascular status of the candidates and modification of the immunosuppression protocol in order to avoid serious infections and long hospital stays.
“老年对老年”项目即欧洲老年项目(ESP),在一个狭小的地理区域内,将年龄≥65岁的供者分配给年龄≥65岁的受者,以尽量缩短冷缺血时间,减少等待肾移植的老年患者的等待时间,并扩大该群体的移植资源。ESP在希腊未正式应用。在我们中心,自2003年以来,对于有肾移植候选资格的老年患者一直采用“老年对老年”标准。
我们旨在通过检查受者和移植物的5年实际生存率,回顾性评估年龄≥65岁的供者到年龄≥65岁的受者的肾移植结果(老年对老年组)。我们中心进行了10例老年对老年肾移植,并在5年随访期间评估移植物和患者生存率。将该组与10例年龄<65岁的受者组成的对照组进行比较,这些受者接受了年龄≥65岁的已故供者的移植物;结果发现,老年对老年组的移植物和患者生存率(分别为50%和58%)显著低于对照组,对照组的移植物和患者生存率分别为72%和80%(P<0.05)。主要死亡原因是心血管疾病。
需要进行更多患者数量的研究,以评估老年移植患者与等待肾移植透析患者之间的生存结果,从而得出老年对老年移植是否有益的结论。同样重要的是,要考虑进行更好的移植前医学评估,关注候选者的心血管状况,并调整免疫抑制方案,以避免严重感染和长时间住院。